Last-Minute Memo Roils MAOs’ Third-Party Marketing Plans

Just eight days into the marketing period for the 2022 Medicare plan year, CMS issued a memo on third-party marketing that, while expected, has led to some confusion among Medicare Advantage plans and their industry partners regarding already finalized marketing materials.

© 2021 MMIT

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues, including drug benefits and specialty pharmacy, for more than a decade. She served as editor of Drug Benefit News (the predecessor to Radar on Drug Benefits) from 2004 to 2005 and again from 2011 to 2016, and now manages Radar on Medicare Advantage. Lauren graduated from Vassar College with a B.A. in English.

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/12/WordPress-Featured_AdobeStock_363940192.jpg
December 2

Recent MA Coding Complaints Signal DOJ’s ‘Evolving Expectations’

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/09/WordPress-Featured-Image-radar-on-medicare-advantage-With-More-Online-Enrollment-MAOs-Must-Add-‘Personal-Touch.jpg
December 2

In AEP Home Stretch, MAOs Make Final Push for Enrollment

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/12/WordPress-Featured_AdobeStock_176084659.jpg
December 2

Expecting Hot Medicare AEP, E-Brokers Beefed Up Internal Sales Forces

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today